EGFR and colorectal carcinoma: In KRYSTAL-1 (NCT03785249) and KRYSTAL-10 (NCT04793958), adagrasib was compared with cetuximab, an anti-EGFR monoclonal antibody, in patients with metastatic KRASG12C-mutated CRC.